Marico Ltd. (MARICO) — Tipsheet

Marico's Q1 volume growth hits double digits, highest in quarters

Tipsheet Editorial — Thu, 02 Jul 2026 16:07:31 GMT

Domestic volume accelerates; consolidated revenue seen rising in early twenties. Copra cost tailwind helps margins, but Saffola Oils volume dips amid supply rationalisation.

What’s new

Domestic volume growth accelerated to double-digit, highest in several quarters.
Consolidated revenue expected to rise in early twenties, led by broad-based performance.
Saffola Oils volume declined as the company rationalised supply to protect margins.

Why it matters

Marico's return to double-digit volume growth is a welcome reversal after sluggish quarters, but the market already anticipated this. The copra cost tailwind gives room to invest without margin damage, yet the Saffola Oils dip shows the trade-off between protecting profitability and defending market share.

What we’re watching

Whether the volume momentum sustains through the rest of FY27.
How A&P spend intensity evolves — Marico sharply increased it this quarter.
Bangladesh slowdown: transient or structural?

The full read

Marico's domestic volume growth hit double digits in Q1, the highest in several quarters. The Parachute rebound is real. Consolidated revenue is expected to rise in the early twenties, with copra costs down 45% from peak funding a sharp increase in advertising investments. The international business delivered mid-teens constant-currency growth, though Bangladesh slowed temporarily. Saffola Oils volume fell as Marico pruned unprofitable variants — a reminder that volume gains come with trade-offs. The gear shift is unmistakable.

Primary source: BSE · NSE

Marico's lead independent director retires, board fills gaps

Tipsheet Editorial — Wed, 01 Jul 2026 13:16:54 GMT

Milind Barve cites persistent health issues for retirement effective August 1, 2026. Succession is immediate and orderly with Girish Paranjpe and Apurva Purohit taking over committee chairs.

What’s new

Milind Barve, Marico's Lead Independent Director, retires due to health issues.
Barve chaired Audit, Risk Management, and Stakeholders Relationship committees.
Board appoints Girish Paranjpe (Audit & Risk) and Apurva Purohit (Stakeholders) as successors.

Why it matters

Losing an experienced Lead Independent Director who chaired three key committees is a governance loss. But the board moved same-day to fill committee chairs from within, keeping oversight intact. No business disruption.

What we’re watching

Whether Marico will appoint a new Lead Independent Director or leave the role vacant.
Any further board changes in the coming quarters.
Investor feedback on governance continuity at the next AGM.

The full read

Milind Barve, Marico's Lead Independent Director and chair of three key committees, is retiring on August 1, 2026, citing persistent health issues. The board acknowledged his July 1 letter and acted immediately: Girish Paranjpe takes over the Audit and Risk Management committees, Apurva Purohit chairs the Stakeholders Relationship Committee from the next day. For a large-cap consumer company, losing an experienced independent director is notable. But the orderly succession, all replacements drawn from the existing board, means no governance vacuum. The market is unlikely to react; this is health-driven, not strategic. The open question is whether Marico will name a new Lead Independent Director or leave the role open.

Primary source: BSE · NSE

Marico puts protein shampoo into a ₹10,000+ crore market

Tipsheet Editorial — Tue, 26 May 2026 13:59:32 GMT

The company's first major brand extension in hair cleansing targets a large segment, but offers no numbers on how much it expects to make.

What’s new

Marico launched Parachute Advanced Protein Shampoo, its first new product in the hair-cleansing category.
The segment is valued at over ₹10,000 crore, a significant adjacency for the Parachute brand.
The company called the launch its most significant in recent years but gave no financial guidance.

Why it matters

For a ₹1 lakh crore company, a new product launch is about portfolio positioning, not immediate earnings impact. The size of the addressable market is large, but Marico's ability to take share from incumbents is the real question. The lack of any financial targets suggests this is a long-game bet, not a near-term catalyst.

What we’re watching

Early sales data and distribution footprint in coming quarters.
Any pricing strategy that signals how Marico will compete with HUL and P&G.
Whether the launch forces a response from existing players.

The full read

Marico is moving Parachute into the ₹10,000+ crore hair-cleansing market. The launch of Parachute Advanced Protein Shampoo is the company's first major play in a category dominated by HUL and P&G. For a company with a market cap over ₹1 lakh crore, the scale of the opportunity is clear. What's missing is any sense of scale for the execution. The filing offered zero financial targets. This is a long-term brand bet, not a near-term earnings lever. The open question is whether Parachute's brand equity can translate from coconut oil into a crowded shampoo aisle.

Primary source: BSE · NSE